Login / Signup

Population pharmacokinetics and dosage optimization of linezolid in Chinese older patients.

Yuanchen LiQiu FangZejun WuSiqi HuangWeihong GeJizhong ShenHuai-Jun Zhu
Published in: European journal of clinical pharmacology (2024)
The results of this study indicated that the standard dose was associated with a risk of overexposure in older patients, particularly those with high SUA values; these patients would benefit from a lower dose (300 mg every 12 h).
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • prognostic factors